Department of Experimental Medicine, Research Institute for Complex Issues of Cardiovascular Diseases, 650002 Kemerovo, Russia.
Int J Mol Sci. 2022 Jun 16;23(12):6736. doi: 10.3390/ijms23126736.
A 72-year-old female patient with mixed rheumatic mitral valve disease and persistent atrial fibrillation underwent mitral valve replacement and suffered from a combined thrombosis of the bioprosthetic valve and the left atrium as soon as 2 days post operation. The patient immediately underwent repeated valve replacement and left atrial thrombectomy. Yet, four days later the patient died due to the recurrent prosthetic valve and left atrial thrombosis which both resulted in an extremely low cardiac output. In this patient's case, the thrombosis was notable for the resistance to anticoagulant therapy as well as for aggressive neutrophil infiltration and release of neutrophil extracellular traps (NETs) within the clot, as demonstrated by immunostaining. The reasons behind these phenomena remained unclear, as no signs of sepsis or contamination of the BHV were documented, although the patient was diagnosed with inherited thrombophilia that could impede the fibrinolysis. The described case highlights the hazard of immunothrombosis upon valve replacement and elucidates its mechanisms in this surgical setting.
一位 72 岁女性患者,患有混合性风湿性二尖瓣疾病和持续性心房颤动,接受了二尖瓣置换术,但术后仅 2 天就出现了生物瓣和左心房的合并血栓形成。患者立即接受了重复的瓣膜置换和左心房血栓切除术。然而,四天后,患者因复发性人工瓣膜和左心房血栓形成而死亡,这两种情况都导致心输出量极低。在本例患者中,血栓形成的特点是对抗凝治疗有抵抗力,以及在血栓内有大量中性粒细胞浸润和释放中性粒细胞胞外陷阱(NETs),免疫染色显示了这一点。尽管患者被诊断为遗传性血栓形成倾向,可能会阻碍纤维蛋白溶解,但这些现象的原因仍不清楚,因为没有记录到败血症或生物瓣污染的迹象。所描述的病例强调了瓣膜置换术后免疫血栓形成的危险,并阐明了其在这种手术环境下的机制。